{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:34:11Z","timestamp":1790109251046,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26483-2","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:01:44Z","timestamp":1764248504000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metabolic dysfunction-associated steatotic liver disease is associated with androgenetic alopecia in adults with stronger effects in women and unhealthy lifestyles"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2128-0924","authenticated-orcid":false,"given":"Sina","family":"Bazmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Saeed","family":"Soleimani-Meigoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Fardaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Mohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Homayounfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babak","family":"Pezeshki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Farjam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"26483_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.reth.2022.10.005","volume":"21","author":"Y Shimizu","year":"2022","unstructured":"Shimizu, Y., Ntege, E. H., Sunami, H. & Inoue, Y. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature. Regen Ther. 21, 527\u2013539. https:\/\/doi.org\/10.1016\/j.reth.2022.10.005 (2022).","journal-title":"Regen Ther."},{"key":"26483_CR2","doi-asserted-by":"publisher","unstructured":"Ruksiriwanich, W. et al. Guava (Psidium guajava L.) Leaf Extract as Bioactive Substances for Anti-Androgen and Antioxidant Activities. Plants (Basel) 11, https:\/\/doi.org\/10.3390\/plants11243514 (2022).","DOI":"10.3390\/plants11243514"},{"key":"26483_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14764172.2024.2362126","volume":"26","author":"A Rosenthal","year":"2024","unstructured":"Rosenthal, A., Conde, G., Greco, J. F. & Gharavi, N. M. Management of androgenic alopecia: a systematic review of the literature. J. Cosmet. Laser Ther. 26, 1\u201316. https:\/\/doi.org\/10.1080\/14764172.2024.2362126 (2024).","journal-title":"J. Cosmet. Laser Ther."},{"key":"26483_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12020-017-1280-y","volume":"57","author":"F Lolli","year":"2017","unstructured":"Lolli, F. et al. Androgenetic alopecia: a review. Endocrine 57, 9\u201317 (2017).","journal-title":"Endocrine"},{"key":"26483_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1159\/000530681","volume":"239","author":"Y Deng","year":"2023","unstructured":"Deng, Y. et al. Cellular senescence: ageing and androgenetic alopecia. Dermatology 239, 533\u2013541. https:\/\/doi.org\/10.1159\/000530681 (2023).","journal-title":"Dermatology"},{"key":"26483_CR6","doi-asserted-by":"publisher","first-page":"8592","DOI":"10.1021\/acs.nanolett.2c03119","volume":"22","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Machine learning guided discovery of superoxide dismutase nanozymes for androgenetic alopecia. Nano Lett. 22, 8592\u20138600. https:\/\/doi.org\/10.1021\/acs.nanolett.2c03119 (2022).","journal-title":"Nano Lett."},{"key":"26483_CR7","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/npmj.npmj_47_24","volume":"31","author":"SO Oiwoh","year":"2024","unstructured":"Oiwoh, S. O., Enitan, A. O., Adegbosin, O. T., Akinboro, A. O. & Onayemi, E. O. Androgenetic alopecia: A review. Niger Postgrad. Med. J. 31, 85\u201392. https:\/\/doi.org\/10.4103\/npmj.npmj_47_24 (2024).","journal-title":"Niger Postgrad. Med. J."},{"key":"26483_CR8","doi-asserted-by":"crossref","unstructured":"Khang, A. R., Lee, H. W., Yi, D., Kang, Y. H. & Son, S. M. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National health and nutrition examination survey 2010\u20132011. Diabetes Metabolic Syndrome Obesity: Targets Therapy, 181\u2013190 (2019).","DOI":"10.2147\/DMSO.S189544"},{"key":"26483_CR9","doi-asserted-by":"publisher","first-page":"e479","DOI":"10.1097\/MD.0000000000000479","volume":"94","author":"J You","year":"2015","unstructured":"You, J. et al. Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis. Medicine 94, e479 (2015).","journal-title":"Medicine"},{"key":"26483_CR10","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3350\/cmh.2024.0431","volume":"31","author":"ZM Younossi","year":"2025","unstructured":"Younossi, Z. M., Kalligeros, M. & Henry, L. Epidemiology of metabolic dysfunction-associated steatotic liver disease. Clin. Mol. Hepatol. 31, 32\u2013s50. https:\/\/doi.org\/10.3350\/cmh.2024.0431 (2025).","journal-title":"Clin. Mol. Hepatol."},{"key":"26483_CR11","doi-asserted-by":"publisher","first-page":"1215790","DOI":"10.3389\/fendo.2023.1215790","volume":"14","author":"A Cui","year":"2023","unstructured":"Cui, A. et al. Causal association of NAFLD with osteoporosis, fracture and falling risk: a bidirectional Mendelian randomization study. Front. Endocrinol. 14, 1215790 (2023).","journal-title":"Front. Endocrinol."},{"key":"26483_CR12","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"ZM Younossi","year":"2023","unstructured":"Younossi, Z. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology 77, 1335\u20131347 (2023).","journal-title":"Hepatology"},{"key":"26483_CR13","doi-asserted-by":"publisher","first-page":"100485","DOI":"10.1016\/j.jlr.2023.100485","volume":"65","author":"ME Rinella","year":"2024","unstructured":"Rinella, M. E. & Sookoian, S. From NAFLD to MASLD: updated naming and diagnosis criteria for fatty liver disease. J. Lipid Res. 65, 100485. https:\/\/doi.org\/10.1016\/j.jlr.2023.100485 (2024).","journal-title":"J. Lipid Res."},{"key":"26483_CR14","doi-asserted-by":"publisher","first-page":"e24877","DOI":"10.1371\/journal.pone.0024877","volume":"6","author":"K Hogg","year":"2011","unstructured":"Hogg, K., Wood, C., McNeilly, A. S. & Duncan, W. C. The in utero programming effect of increased maternal androgens and a direct fetal intervention on liver and metabolic function in adult sheep. PLos One. 6, e24877 (2011).","journal-title":"PLos One"},{"key":"26483_CR15","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3390\/biomedicines10061291","volume":"10","author":"KJ Siemienowicz","year":"2022","unstructured":"Siemienowicz, K. J. et al. Hepatic mitochondrial dysfunction and risk of liver disease in an ovine model of PCOS males. Biomedicines 10, 1291 (2022).","journal-title":"Biomedicines"},{"key":"26483_CR16","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/2229-5178.137776","volume":"5","author":"OA Bakry","year":"2014","unstructured":"Bakry, O. A., Shoeib, M. A. M., Shafiee, E., Hassan, A. & M. K. & Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case\u2013control study. Indian Dermatology Online J. 5, 276\u2013281 (2014).","journal-title":"Indian Dermatology Online J."},{"key":"26483_CR17","doi-asserted-by":"publisher","first-page":"1433962","DOI":"10.3389\/fnut.2024.1433962","volume":"11","author":"S Bazmi","year":"2024","unstructured":"Bazmi, S. et al. Androgenic alopecia is associated with higher dietary inflammatory index and lower antioxidant index scores. Front. Nutr. 11, 1433962. https:\/\/doi.org\/10.3389\/fnut.2024.1433962 (2024).","journal-title":"Front. Nutr."},{"key":"26483_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21608\/bjas.2024.319105.1496","volume":"9","author":"DH Ahmed","year":"2024","unstructured":"Ahmed, D. H., Sorour, N. E., Ibraheem, N. F. & Habashy, A. Y. Evaluation of fat mass and obesity associated (FTO) gene polymorphism in male androgentic aloplecia patients. Benha J. Appl. Sci. 9, 1\u20137 (2024).","journal-title":"Benha J. Appl. Sci."},{"key":"26483_CR19","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.3390\/ijerph16183415","volume":"16","author":"V Rosato","year":"2019","unstructured":"Rosato, V. et al. NAFLD and extra-hepatic comorbidities: current evidence on a multi-organ metabolic syndrome. Int. J. Environ. Res. Public Health. 16, 3415 (2019).","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"26483_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam, M. et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa cohort study. BMC public. Health. 16, 1\u20138 (2016).","journal-title":"BMC public. Health"},{"key":"26483_CR21","first-page":"791","volume":"19","author":"M Sartipi","year":"2016","unstructured":"Sartipi, M., Nedjat, S., Mansournia, M. A., Baigi, V. & Fotouhi, A. Assets as a socioeconomic status index: categorical principal components analysis vs. Latent class analysis. Arch. Iran. Med. 19, 791\u2013796 (2016).","journal-title":"Arch. Iran. Med."},{"key":"26483_CR22","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1186\/s12889-016-3760-z","volume":"16","author":"M Farjam","year":"2016","unstructured":"Farjam, M. et al. A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa cohort study. BMC Public. Health. 16, 1090. https:\/\/doi.org\/10.1186\/s12889-016-3760-z (2016).","journal-title":"BMC Public. Health"},{"key":"26483_CR23","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/s12876-024-03535-x","volume":"24","author":"A Saberian","year":"2024","unstructured":"Saberian, A. et al. Determining the sensitivity and specificity of the calculated fatty liver index in comparison with ultrasound. BMC Gastroenterol. 24, 443. https:\/\/doi.org\/10.1186\/s12876-024-03535-x (2024).","journal-title":"BMC Gastroenterol."},{"key":"26483_CR24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230x-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni, G. et al. The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 6, 33. https:\/\/doi.org\/10.1186\/1471-230x-6-33 (2006).","journal-title":"BMC Gastroenterol."},{"key":"26483_CR25","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.3748\/wjg.v22.i10.3023","volume":"22","author":"N Motamed","year":"2016","unstructured":"Motamed, N. et al. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease. World J. Gastroenterol. 22, 3023\u20133030. https:\/\/doi.org\/10.3748\/wjg.v22.i10.3023 (2016).","journal-title":"World J. Gastroenterol."},{"key":"26483_CR26","doi-asserted-by":"publisher","first-page":"e1682","DOI":"10.1097\/md.0000000000001682","volume":"94","author":"X Huang","year":"2015","unstructured":"Huang, X. et al. Validation of the fatty liver index for nonalcoholic fatty liver disease in Middle-Aged and elderly Chinese. Med. (Baltim). 94, e1682. https:\/\/doi.org\/10.1097\/md.0000000000001682 (2015).","journal-title":"Med. (Baltim)."},{"key":"26483_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cgh.2012.12.031","volume":"11","author":"EM Koehler","year":"2013","unstructured":"Koehler, E. M. et al. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin. Gastroenterol. Hepatol. 11, 1201\u20131204. https:\/\/doi.org\/10.1016\/j.cgh.2012.12.031 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"26483_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.2147\/dmso.S189544","volume":"12","author":"AR Khang","year":"2019","unstructured":"Khang, A. R., Lee, H. W., Yi, D., Kang, Y. H. & Son, S. M. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National health and nutrition examination survey 2010\u20132011. Diabetes Metab. Syndr. Obes. 12, 181\u2013190. https:\/\/doi.org\/10.2147\/dmso.S189544 (2019).","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"26483_CR29","doi-asserted-by":"publisher","first-page":"101281","DOI":"10.1016\/j.aohep.2023.101281","volume":"29","author":"S Hong","year":"2024","unstructured":"Hong, S. et al. From NAFLD to MASLD: when metabolic comorbidity matters. Ann. Hepatol. 29, 101281. https:\/\/doi.org\/10.1016\/j.aohep.2023.101281 (2024).","journal-title":"Ann. Hepatol."},{"key":"26483_CR30","doi-asserted-by":"publisher","first-page":"530","DOI":"10.25259\/ijdvl_949_2021","volume":"89","author":"K Vinay","year":"2023","unstructured":"Vinay, K. et al. Clinical and metabolic characteristics of males with early-onset androgenetic alopecia. Indian J. Dermatol. Venereol. Leprol. 89, 530\u2013535. https:\/\/doi.org\/10.25259\/ijdvl_949_2021 (2023).","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"26483_CR31","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4103\/2229-5178.137776","volume":"5","author":"OA Bakry","year":"2014","unstructured":"Bakry, O. A., Shoeib, M. A., Shafiee, E., Hassan, A. & M. K. & Androgenetic alopecia, metabolic syndrome, and insulin resistance: is there any association? A case-control study. Indian Dermatol. Online J. 5, 276\u2013281. https:\/\/doi.org\/10.4103\/2229-5178.137776 (2014).","journal-title":"Indian Dermatol. Online J."},{"key":"26483_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1210\/clinem\/dgab658","volume":"107","author":"C Falzarano","year":"2022","unstructured":"Falzarano, C. et al. Nonalcoholic fatty liver disease in women and girls with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 107, 258\u2013272. https:\/\/doi.org\/10.1210\/clinem\/dgab658 (2022).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"26483_CR33","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","volume":"15","author":"B Kumarendran","year":"2018","unstructured":"Kumarendran, B. et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a united Kingdom primary care database. PLoS Med. 15, e1002542. https:\/\/doi.org\/10.1371\/journal.pmed.1002542 (2018).","journal-title":"PLoS Med."},{"key":"26483_CR34","doi-asserted-by":"publisher","first-page":"101491","DOI":"10.1016\/j.aohep.2024.101491","volume":"29","author":"M Nemer","year":"2024","unstructured":"Nemer, M., Osman, F. & Said, A. Dietary macro and micronutrients associated with MASLD: analysis of a National US cohort database. Ann. Hepatol. 29, 101491. https:\/\/doi.org\/10.1016\/j.aohep.2024.101491 (2024).","journal-title":"Ann. Hepatol."},{"key":"26483_CR35","first-page":"109","volume":"4","author":"M Basaranoglu","year":"2015","unstructured":"Basaranoglu, M., Basaranoglu, G. & Bugianesi, E. Carbohydrate intake and nonalcoholic fatty liver disease: Fructose as a weapon of mass destruction. Hepatobiliary Surg. Nutr. 4, 109 (2015).","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"26483_CR36","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3390\/ph16020206","volume":"16","author":"P Kesika","year":"2023","unstructured":"Kesika, P., Sivamaruthi, B. S., Thangaleela, S., Bharathi, M. & Chaiyasut, C. Role and mechanisms of phytochemicals in hair growth and health. Pharmaceuticals 16, 206 (2023).","journal-title":"Pharmaceuticals"},{"key":"26483_CR37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/nu15010214","volume":"15","author":"X Shi","year":"2023","unstructured":"Shi, X. et al. The association between sugar-sweetened beverages and male pattern hair loss in young men. Nutrients 15, 214 (2023).","journal-title":"Nutrients"},{"key":"26483_CR38","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/j.tifs.2021.06.056","volume":"116","author":"NJ Sadgrove","year":"2021","unstructured":"Sadgrove, N. J. The \u2018bald\u2019phenotype (androgenetic alopecia) is caused by the high glycaemic, high cholesterol and low mineral \u2018western diet\u2019. Trends Food Sci. Technol. 116, 1170\u20131178 (2021).","journal-title":"Trends Food Sci. Technol."},{"key":"26483_CR39","doi-asserted-by":"publisher","first-page":"115251","DOI":"10.1016\/j.celrep.2025.115251","volume":"44","author":"M Chen","year":"2025","unstructured":"Chen, M. et al. Exercise-induced adipokine Nrg4 alleviates MASLD by disrupting hepatic cGAS-STING signaling. Cell. Rep. 44, 115251. https:\/\/doi.org\/10.1016\/j.celrep.2025.115251 (2025).","journal-title":"Cell. Rep."},{"key":"26483_CR40","doi-asserted-by":"publisher","unstructured":"Bucarey, J. L., Trujillo-Gonz\u00e1lez, I., Paules, E. M. & Espinosa, A. Myokines and their potential protective role against oxidative stress in metabolic Dysfunction-Associated steatotic liver disease (MASLD). Antioxid. (Basel). 13. https:\/\/doi.org\/10.3390\/antiox13111363 (2024).","DOI":"10.3390\/antiox13111363"},{"key":"26483_CR41","doi-asserted-by":"publisher","first-page":"1426551","DOI":"10.3389\/fnut.2024.1426551","volume":"11","author":"SP Mambrini","year":"2024","unstructured":"Mambrini, S. P. et al. Diet and physical exercise as key players to tackle MASLD through improvement of insulin resistance and metabolic flexibility. Front. Nutr. 11, 1426551. https:\/\/doi.org\/10.3389\/fnut.2024.1426551 (2024).","journal-title":"Front. Nutr."},{"key":"26483_CR42","doi-asserted-by":"publisher","first-page":"513","DOI":"10.5021\/ad.2017.29.4.513","volume":"29","author":"J Choi","year":"2017","unstructured":"Choi, J., Jun, M., Lee, S., Oh, S. S. & Lee, W. S. The association between exercise and androgenetic alopecia: a survey-based study. Ann. Dermatol. 29, 513\u2013516 (2017).","journal-title":"Ann. Dermatol."},{"key":"26483_CR43","doi-asserted-by":"publisher","first-page":"738","DOI":"10.4254\/wjh.v6.i10.738","volume":"6","author":"K Tziomalos","year":"2014","unstructured":"Tziomalos, K. Lipid-lowering agents in the management of nonalcoholic fatty liver disease. World J. Hepatol. 6, 738\u2013744. https:\/\/doi.org\/10.4254\/wjh.v6.i10.738 (2014).","journal-title":"World J. Hepatol."},{"key":"26483_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4254\/wjh.v14.i1.119","volume":"14","author":"I Tzanaki","year":"2022","unstructured":"Tzanaki, I., Agouridis, A. P. & Kostapanos, M. S. Is there a role of lipid-lowering therapies in the management of fatty liver disease? World J. Hepatol. 14, 119\u2013139. https:\/\/doi.org\/10.4254\/wjh.v14.i1.119 (2022).","journal-title":"World J. Hepatol."},{"key":"26483_CR45","doi-asserted-by":"publisher","first-page":"116","DOI":"10.14309\/ajg.0000000000000845","volume":"116","author":"JI Lee","year":"2021","unstructured":"Lee, J. I., Lee, H. W., Lee, K. S., Lee, H. S. & Park, J. Y. Effects of Statin use on the development and progression of nonalcoholic fatty liver disease: A nationwide nested Case-Control study. Am. J. Gastroenterol. 116, 116\u2013124. https:\/\/doi.org\/10.14309\/ajg.0000000000000845 (2021).","journal-title":"Am. J. Gastroenterol."},{"key":"26483_CR46","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1161\/CIRCRESAHA.119.315896","volume":"126","author":"H Wu","year":"2020","unstructured":"Wu, H. & Ballantyne, C. M. Metabolic inflammation and insulin resistance in obesity. Circul. Res. 126, 1549\u20131564 (2020).","journal-title":"Circul. Res."},{"key":"26483_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13555-016-0160-3","volume":"7","author":"G Gonz\u00e1lez-Saldivar","year":"2017","unstructured":"Gonz\u00e1lez-Saldivar, G., Rodr\u00edguez-Guti\u00e9rrez, R., Ocampo-Candiani, J. & Gonz\u00e1lez-Gonz\u00e1lez, J. G. G\u00f3mez-Flores, M. Skin manifestations of insulin resistance: from a biochemical stance to a clinical diagnosis and management. Dermatol. Ther. (Heidelb). 7, 37\u201351. https:\/\/doi.org\/10.1007\/s13555-016-0160-3 (2017).","journal-title":"Dermatol. Ther. (Heidelb)"},{"key":"26483_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4103\/ijd.IJD_724_16","volume":"64","author":"MR Swaroop","year":"2019","unstructured":"Swaroop, M. R. et al. The association of metabolic syndrome and insulin resistance in Early-Onset androgenetic alopecia in males: A Case-Control study. Indian J. Dermatol. 64, 23\u201327. https:\/\/doi.org\/10.4103\/ijd.IJD_724_16 (2019).","journal-title":"Indian J. Dermatol."},{"key":"26483_CR49","doi-asserted-by":"publisher","first-page":"e1002542","DOI":"10.1371\/journal.pmed.1002542","volume":"15","author":"B Kumarendran","year":"2018","unstructured":"Kumarendran, B. et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: a longitudinal study based on a united Kingdom primary care database. PLoS Med. 15, e1002542 (2018).","journal-title":"PLoS Med."},{"key":"26483_CR50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12876-025-03625-4","volume":"25","author":"X Qiu","year":"2025","unstructured":"Qiu, X. et al. Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017\u20132020. BMC Gastroenterol. 25, 42 (2025).","journal-title":"BMC Gastroenterol."},{"key":"26483_CR51","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jaad.2021.09.040","volume":"86","author":"J Plante","year":"2022","unstructured":"Plante, J., Valdebran, M., Forcucci, J., Lucas, O. & Elston, D. Perifollicular inflammation and follicular spongiosis in androgenetic alopecia. J. Am. Acad. Dermatol. 86, 437\u2013438 (2022).","journal-title":"J. Am. Acad. Dermatol."},{"key":"26483_CR52","first-page":"317","volume":"13","author":"F Sari Aslani","year":"2018","unstructured":"Sari Aslani, F., Heidari Esfahani, M. & Sepaskhah, M. Non-scarring alopecias in Iranian patients: A histopathological study with hair counts. Iran. J. Pathol. 13, 317\u2013324 (2018).","journal-title":"Iran. J. Pathol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26483-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26483-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T13:01:45Z","timestamp":1764248505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26483-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["26483"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26483-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adhered strictly to the ethical principles set forth in the Declaration of Helsinki. All participants received comprehensive information regarding the study\u2019s objectives, procedures, and their rights before enrollment, and each provided written informed consent. Participation was completely voluntary, and individuals retained the right to withdraw at any time without any repercussions. The study protocol received formal approval from the institutional ethics committee of Fasa University of Medical Sciences under the reference number IR.FUMS.REC.1400.015.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"42399"}}